1776 Wealth’s Amgen AMGN Stock Holding History

1776 Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-252	Closed	-$59K	–	121
2020 Q2	$59K	Buy	+252	New	+$57.5K	0.04%	185

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

1776 Wealth's AMGN Position: Q3 2020 in Review

1776 Wealth sold out of Amgen (AMGN) in Q3 2020, closing a stake of 252 shares — an estimated $59K sold.

1776 Wealth first reported a position in AMGN in Q2 2020 and held it in 1 quarter. The position peaked at $59K in Q2 2020. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

1776 Wealth reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
1776 Wealth sold 252 Amgen shares in Q3 2020, an estimated $59K.
1776 Wealth first reported a position in Amgen in Q2 2020 and held it in 1 quarter.
1776 Wealth's Amgen position peaked at $59K in Q2 2020.
2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.